Data exclusivity: Encouraging development of new medicines
Related news and resources
Pharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security
Ahead of the G7 Leaders’ Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry’s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.
Read more
Open letter from the innovative pharmaceutical industry to G20 Ministers in support of the G20 Health Agenda
On 17 April 2025, IFPMA and IPASA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda.
Read moreTrade and Health Agenda: A Meaningful World Trade Organization Roadmap to Strengthen Global Health
Ahead of the 14th WTO Ministerial Conference (MC14), trade associations representing the pharmaceutical industry provide a perspective on how WTO Members can a roadmap to strengthen global health through meaningful trade policies.
Read more